{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:55:23Z","timestamp":1790625323757,"version":"4.1.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm typically defined by\n                      <jats:italic toggle=\"yes\">BCR::ABL1<\/jats:italic>\n                      p210 fusions isoforms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Observations:<\/jats:title>\n                    <jats:p>\n                      An 8-year-old female CML patient harbored a typical t(9;22)(q34;11) Philadelphia chromosome and\n                      <jats:italic toggle=\"yes\">BCR::ABL1<\/jats:italic>\n                      fusion by conventional karyotyping and FISH but lacked\n                      <jats:italic toggle=\"yes\">BCR::ABL1<\/jats:italic>\n                      p210 fusion transcripts by RT-PCR. Targeted next-generation sequencing (NGS) revealed\n                      <jats:italic toggle=\"yes\">BCR<\/jats:italic>\n                      ::\n                      <jats:italic toggle=\"yes\">SPECC1L<\/jats:italic>\n                      ::\n                      <jats:italic toggle=\"yes\">ABL1<\/jats:italic>\n                      fusion transcripts predicted to encode an in-frame BCR-exon-8::SPECC1L-exon-4::ABL1-exon-2 fusion protein retaining the tyrosine kinase domain. FISH and NGS were used for therapeutic imatinib monitoring given this atypical isoform.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This case highlights the role of multimodal molecular diagnostics to diagnose and monitor pediatric CML patients with atypical fusion isoforms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mph.0000000000003259","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:00:10Z","timestamp":1786374010000},"page":"e318-e322","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A Rare BCR::SPECC1L::ABL1 Fusion in a Pediatric Chronic Myeloid Leukemia Patient"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6453-5141","authenticated-orcid":false,"given":"Ege","family":"Cubuk","sequence":"first","affiliation":[{"name":"Department of Pathology & Immunology, Baylor College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindita","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of Pathology & Immunology, Baylor College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1827-7879","authenticated-orcid":false,"given":"Pamela E.","family":"Camacho","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1458-9675","authenticated-orcid":false,"given":"Andrea N.","family":"Marcogliese","sequence":"additional","affiliation":[{"name":"Department of Pathology & Immunology, Baylor College of Medicine"},{"name":"Department of Pathology, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7248-8576","authenticated-orcid":false,"given":"Angshumoy","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Pathology & Immunology, Baylor College of Medicine"},{"name":"Department of Pathology, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1178-5694","authenticated-orcid":false,"given":"Pulivarthi H.","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Pathology & Immunology, Baylor College of Medicine"},{"name":"Department of Pathology, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9295-1969","authenticated-orcid":false,"given":"Dolores H.","family":"Lopez-Terrada","sequence":"additional","affiliation":[{"name":"Department of Pathology & Immunology, Baylor College of Medicine"},{"name":"Department of Pediatrics, Baylor College of Medicine"},{"name":"Department of Pathology, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3953-1744","authenticated-orcid":false,"given":"Jennifer","family":"Scull","sequence":"additional","affiliation":[{"name":"Department of Pathology & Immunology, Baylor College of Medicine"},{"name":"Department of Pathology, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6179-0937","authenticated-orcid":false,"given":"Kevin E.","family":"Fisher","sequence":"additional","affiliation":[{"name":"Department of Pathology & Immunology, Baylor College of Medicine"},{"name":"Department of Pathology, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"R1-20260928","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood-2015-06-648667","article-title":"Pediatric chronic myeloid leukemia is a unique disease that requires a different approach","volume":"127","author":"Hijiya","year":"2016","journal-title":"Blood"},{"key":"R2-20260928","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"R3-20260928","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.hemonc.2020.08.003","article-title":"Impact of the major BCR-ABL1 transcript type on clinical and biological parameters and molecular response in patients with chronic myeloid leukemia","volume":"15","author":"Nachi","year":"2022","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"R4-20260928","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/s41375-025-02664-w","article-title":"2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia","volume":"39","author":"Apperley","year":"2025","journal-title":"Leukemia"},{"key":"R5-20260928","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/ng.3466","article-title":"Exploring genomic alteration in pediatric cancer using ProteinPaint","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"key":"R6-20260928","doi-asserted-by":"crossref","first-page":"e2020062","DOI":"10.4084\/mjhid.2020.062","article-title":"Prognostic significance of transcript-type BCR-ABL1 in chronic myeloid leukemia","volume":"12","author":"Molica","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R7-20260928","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.bpj.2022.05.030","article-title":"The structural basis of BCR-ABL recruitment of GRB2 in chronic myelogenous leukemia","volume":"121","author":"Liu","year":"2022","journal-title":"Biophys J"},{"key":"R8-20260928","doi-asserted-by":"crossref","first-page":"43","DOI":"10.6004\/jnccn.2024.0007","article-title":"Chronic myeloid leukemia, version 2.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Shah","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"R9-20260928","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1182\/blood-2010-06-291641","article-title":"Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA","volume":"116","author":"White","year":"2010","journal-title":"Blood"},{"key":"R10-20260928","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1182\/blood-2009-07-229864","article-title":"Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP","volume":"114","author":"Testoni","year":"2009","journal-title":"Blood"},{"key":"R11-20260928","doi-asserted-by":"crossref","first-page":"149370","DOI":"10.1016\/j.gene.2025.149370","article-title":"A multi-modal molecular characterization of the Philadelphia translocation featuring long read sequencing","volume":"950","author":"Yin Law","year":"2025","journal-title":"Gene"},{"key":"R12-20260928","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12920-023-01607-7","article-title":"FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions","volume":"16","author":"May","year":"2023","journal-title":"BMC Med Genomics"},{"key":"R13-20260928","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/s41375-018-0341-4","article-title":"The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview","volume":"33","author":"Baccarani","year":"2019","journal-title":"Leukemia"},{"key":"R14-20260928","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/gcc.22263","article-title":"Molecular characterization and follow-up of five CML patients with new BCR-ABL1 fusion transcripts","volume":"54","author":"Huet","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"R15-20260928","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3343\/alm.2018.38.2.169","article-title":"A novel e8a2BCR-ABL1 fusion transcript without insertion sequence in a patient with chronic myeloid leukemia","volume":"38","author":"Jin","year":"2018","journal-title":"Ann Lab Med"},{"key":"R16-20260928","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.leu.2404012","article-title":"Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript","volume":"20","author":"Tchirkov","year":"2006","journal-title":"Leukemia"},{"key":"R17-20260928","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3324\/haematol.2025.288283","article-title":"Children with chronic-phase chronic myeloid leukemia: characteristics and outcomes from the International Registry of Childhood CML","volume":"111","author":"Millot","year":"2026","journal-title":"Haematologica"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:00:20Z","timestamp":1790622020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003259","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"2026-02-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}